ผศ.ดร.คณุตม์ จารุธรรมโสภณ
Asst. Prof. Dr.KANOOT JARUTHAMSOPHON
E-mail:
jkanoot@medicine.psu.ac.th
Education
- 2014 ว.ว. (พยาธิวิทยาคลินิค) แพทยสภา กระทรวงสาธารณสุข, Thailand
- Kanoot Jaruthamsophon. 2021. "No Evidence of Abnormal Expression of Beta-Catenin and Bcl-2 Proteins in Pilomatricoma as One Clinical Feature of Tetrasomy 9p Syndrome". International Journal of Pediatrics (United Kingdom), 2021 (Article number :2612846) : 1-8
- Kanoot Jaruthamsophon. 2022. "HLA Allele-Restricted Immune-Mediated Adverse Drug Reactions: Framework for Genetic Prediction". Annual review of pharmacology and toxicology, ุ62 (-) : 509-529
- Kanoot Jaruthamsophon. 2021. "Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis". Pharmacogenomics Journal, 21 (6) : ุ682-690
- Kanoot Jaruthamsophon. 2022. "Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients". Chemical Research in Toxicology, 35 (11) : 2122-2132
- Kanoot Jaruthamsophon. 2023. "Characterization of Drug-Specific CD4+ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions". Chemical Research in Toxicology, 36 (5) : 757-768
- Kanoot Jaruthamsophon. 2024. "Molecular identification of HLA-B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription". Clinical and Translational Science, 17 (6 Article number : e13867) : 1-8
- Kanoot Jaruthamsophon. 2024. "COVID-19 impact on blood donor characteristics and seroprevalence of transfusion-transmitted infections in southern Thailand between 2018 and 2022". Scientific Reports, 14 (1) : 1-12
- Kanoot Jaruthamsophon. 2025. "Long-Term Evaluation of Allopurinol Effectiveness in the Thai Population: Insights from 10 Years of Real-World Big Data Analysis". Journal of Health Science and Medical Research, 43 (2) : ---
- Kanoot Jaruthamsophon. 2021. "Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01". Frontiers in Immunology, 12 (-) : ---
Interest
